- Home
- IOVA vs CVE Comparison
IOVA vs CVE Comparison
Compare IOVA & CVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- CVE
- Stock Information
- Founded
- IOVA 2007
- CVE 2009
- Country
- IOVA United States
- CVE Canada
- Employees
- IOVA N/A
- CVE N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- CVE Oil & Gas Production
- Sector
- IOVA Health Care
- CVE Energy
- Exchange
- IOVA Nasdaq
- CVE Nasdaq
- Market Cap
- IOVA 771.4M
- CVE 23.5B
- IPO Year
- IOVA N/A
- CVE N/A
- Fundamental
- Price
- IOVA $1.88
- CVE $14.66
- Analyst Decision
- IOVA Buy
- CVE Strong Buy
- Analyst Count
- IOVA 10
- CVE 4
- Target Price
- IOVA $12.22
- CVE $25.75
- AVG Volume (30 Days)
- IOVA 10.4M
- CVE 12.9M
- Earning Date
- IOVA 08-07-2025
- CVE 07-31-2025
- Dividend Yield
- IOVA N/A
- CVE 3.62%
- EPS Growth
- IOVA N/A
- CVE N/A
- EPS
- IOVA N/A
- CVE 1.05
- Revenue
- IOVA $212,679,000.00
- CVE $37,926,044,442.00
- Revenue This Year
- IOVA $86.62
- CVE N/A
- Revenue Next Year
- IOVA $69.95
- CVE N/A
- P/E Ratio
- IOVA N/A
- CVE $13.94
- Revenue Growth
- IOVA 11070.12
- CVE 2.85
- 52 Week Low
- IOVA $1.64
- CVE $10.23
- 52 Week High
- IOVA $12.51
- CVE $20.76
- Technical
- Relative Strength Index (RSI)
- IOVA 47.47
- CVE 60.60
- Support Level
- IOVA $1.68
- CVE $14.16
- Resistance Level
- IOVA $2.02
- CVE $14.79
- Average True Range (ATR)
- IOVA 0.11
- CVE 0.39
- MACD
- IOVA 0.03
- CVE 0.03
- Stochastic Oscillator
- IOVA 61.42
- CVE 89.77
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About CVE Cenovus Energy Inc
Cenovus Energy Inc is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 786 thousand barrels of oil equivalent per day in 2022. The company had upstream projects across Western Canada; crude oil production and natural gas and NGLs production offshore China and Indonesia. The downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada.